1. Home
  2. HRMY vs RLJ Comparison

HRMY vs RLJ Comparison

Compare HRMY & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.03

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ

RLJ Lodging Trust of Beneficial Interest $0.01 par value

HOLD

Current Price

$11.78

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
RLJ
Founded
2017
2011
Country
United States
United States
Employees
N/A
75
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
RLJ
Price
$37.03
$11.78
Analyst Decision
Buy
Hold
Analyst Count
9
6
Target Price
$44.11
$7.83
AVG Volume (30 Days)
854.1K
1.9M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
7.26%
EPS Growth
7.97
N/A
EPS
0.55
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$2.02
Revenue Next Year
$12.88
$2.54
P/E Ratio
$67.75
$188.67
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$6.54
52 Week High
$40.87
$12.11

Technical Indicators

Market Signals
Indicator
HRMY
RLJ
Relative Strength Index (RSI) 68.61 75.94
Support Level $35.05 $7.24
Resistance Level $39.12 N/A
Average True Range (ATR) 1.04 0.30
MACD 0.22 -0.03
Stochastic Oscillator 93.53 72.37

Price Performance

Historical Comparison
HRMY
RLJ

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

Share on Social Networks: